There are many ways companies can help isolated staff feel connected and manage the stresses of a work-life with fewer boundaries, says the Financial Times' Pilita Clark.
The insecurity fueled by COVID-19 will weigh on the global economy long after the worst is in the past, says an economist.
CHINA Life Insurance (Singapore), which normally sells its insurance products through banks and financial companies, now plans to hire more than 500 consultants in Singapore over the next five years to provide a more dedicated service to its clients.
DBS has been named the best bank in the world by New York-based financial publication Global Finance, marking the third year in a row that the Singapore-headquartered bank has received the accolade from a financial publication.
The NZDUSD pair started off the year uneventfully by making a series of slow descends from 0.6757 to 0.6193 from the period of January to March 2020. The Covid-19 pandemic, which escalated in March, stirred up high levels of volatility and exacerbated the downward descend by twice...
The Canadian government will extend its coronavirus rent-relief program for small businesses into September, the Globe and Mail reported late on Saturday, citing sources familiar with the policy discussions.
The French state will look with "fairness" at waste and water management company Veolia's offer for Engie's stake in Suez as well as at any other offer that could emerge, Finance Minister Bruno Le Maire said on Sunday.
Credit Suisse may have spied on more employees under its former chief executive Tidjane Thiam, Swiss newspaper SonntagsZeitung reported on Sunday, citing evidence of two further instances that had previously been undisclosed.
REUTERS: The U.S. Securities and Exchange Commission is examining claims from a whistleblower that Rio Tinto was aware of problems at its underground copper mine extension project of Oyu Tolgoi in Mongolia months before the miner confirmed the project would face delays and higher costs, the ...
A coronavirus vaccine that Sanofi is developing with Britain's GlaxoSmithKline is likely to be priced at less than 10 euros (US$11.80) per shot if it is approved for use, Sanofi's chief in France said on Saturday.
